Anhui Biochem Pharmaceutical Co., Ltd. ( China (Mainland))

Anhui Biochem United Pharmaceutical Co., Ltd. is one of the leading pharmaceutical manufacturing enterprises in China specializing in the development of Anti-HIV/AIDS intermediates, active pharmaceutical ingredients (APIs) and finished pharmaceutical products (FPPs). The total site area of the company is 205,128m²(308 acres), including the API manufacturing site of 110,556 m² (166 acres), the FPPs manufacturing site of 77,256 m²(116 acres) and the R&D base of 17,316 m² (26 acres).

The company has been approved by China SFDA. Lafutidine (118288-08-7) API and Lamivudine (134678-17-4) API has been approved by China SFDA with GMP certificate. Lamivudine API has also been approved by Health Canada. Selegiline Hydrochloride (14611-52-0) Capsule which approved by China SFDA with GMP certificate has come onto the market. Now we are registering it and looking for business partners around the world.

The company has established a well-equipped R&D team with 5 Doctors and 12 Masters, they are working under the direction of the senior engineers who are honored by the State Council subsidy.